Navigation Links
Allergies: standardisation, regulation and clinical trials breakthroughs with Stallergenes Greer, HAL Allergy, Nestle & LETI
Date:3/23/2017

LONDON, March 23, 2017 /PRNewswire/ -- As a result of diagnostic technology increasing throughout the years along with the prevalence of allergic diseases, cutting edge developments in targeted drugs and preventative measures are currently revolutionising the ways in which pharmaceutical and biotech companies are addressing allergies.

Allergies 2017 promises to be both a high quality meeting and a platform for discussion amongst the allergy interest groups, immunologists, research scholars and doctors. The event will also provide an informal networking opportunity where new collaborations or working partnerships are formed and old ones renewed to address topical themes including the current status and key challenges that the allergies industry is facing.

Hear more on purified allergens and immunoassays for molecular diagnostics, product standardisation and food safety from Indoor Biotechnology at this year's London based conference. Presentations and selected case studies from industry experts and chairs will include:

Discovery and early clinical evaluation of the intranasal TLR-7 agonist GSK2245035 in allergic disease

  • Discovery of the potent and highly selective Toll-like receptor 7 agonist GSK2245035
  • Potential mechanism of action as a disease modifying treatment
  • Safety, pharmacodynamics and efficacy of intranasal TLR-7 agonist GSK2245035 in allergic rhinitis

Antoon van Oosterhout, Vice President & Head Allergic Inflammation Discovery Performance Unit, GSK

Applications and mechanisms of immunotherapy in allergic rhinitis and asthma

  • Clinical and immunologic tolerance as hallmarks of successful allergen immunotherapy (AIT)
  • Effect of AIT on innate effector cells
  • The associated induction of distinct phenotypes of regulatory T and B cells during treatment with allergen immunotherapy

Mohamed Shamji, Senior Lecturer (Associate Professor) in Immunology and Allergy, Imperial College London

Indoor Biotechnologies have now joined our sponsorship line-up alongside DBV Technologies, Indoor Biotechnologies.

Other event highlights include:

  • Featured spotlight on unique DNA based vaccines for the treatment of allergies
  • Over 16 presentations from a notable panel of speakers featuring Stallergenes Greer, HAL Allergy, Nestle, LETI, Imperial College London, UCL + MORE!
  • Highlight the latest innovative strategies to tackling allergies ranging from food to pollution
  • Insight into molecular diagnostics and biomarkers for allergic disease
  • Discuss challenges and potential solutions to in patient recruitment and phenology
  • Develop a deeper understanding of the ongoing problems still facing chronic allergy sufferers

There is currently an £400 early bird discount for all registrations made before March 31st. For more registration details please visit www.allergies-event.com

4th Allergies Conference
6th – 7th July 2017
London, UK
www.allergies-event.com

Photo(s):
https://www.prlog.org/12628460

Press release distributed by PRLog

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/allergies-standardisation-regulation-and-clinical-trials-breakthroughs-with-stallergenes-greer-hal-allergy-nestle--leti-300428589.html


'/>"/>
SOURCE SMi Group
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Hopeful of Reduced Regulation, Biotech Stocks Stay the Course with Advanced Drug Developments
2. This Years Crafoord Prize is Awarded for Fundamental Discoveries in Immune Regulation
3. Medical Marijuana Temporary Regulations for Dispensaries to be Published in Tomorrows Pennsylvania Bulletin
4. Parenteral Drug Association Celebrates 70 Years of Connecting People, Science and Regulation
5. Pennsylvania Department of Health Seeks Public Input on Medical Marijuana Programs Temporary Regulation for Dispensaries/Laboratories
6. Evana Automation Launches New Validation Program to Assist Healthcare Product Manufacturers with Meeting FDA Regulations during the Implementation of Automated Manufacturing Equipment
7. Global Market Study on Hearing Protection Devices: Stringent Safety Regulations and Increasing Demand for Reusable Earplugs to Drive the Market, Persistence Market Research
8. Global Disposable Medical Device Sensors Market 2015-2020 - Amendments in Regulations for Ingestible Sensors a Major Market Opportunity
9. Med-X, Inc. Launches Cannabis Industrys First Regulation A+ Equity Crowdfunding Campaign
10. InfiniTrak Announces New Solution for Community Pharmacies Facing FDA Regulations
11. Italian Therapeutic Drug Monitoring (TDM) Market 2016 - Changes Will be Caused by Convergence of New and More Stringent Regulations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/8/2017)... 2017   Responding to Heath Ledger,s father,s ... of singer Chris Cornell in May, the mental ... a free online psychiatric drug side effects ... about psychotropic drug risks. The father of ... an accidental overdose, has called for tighter rules on prescription ...
(Date:6/7/2017)... June 7, 2017  Novavax, Inc., (Nasdaq: NVAX ... Phase 2 trials of its RSV F protein recombinant nanoparticle ... age have been published in the journal Vaccine ... shared in prior scientific conferences). The Company previously announced ... Novavax is developing the RSV F Vaccine with the goal ...
(Date:6/5/2017)... June 5, 2017 Kohll,s Pharmacy & Homecare is the ... the United States . The Raizer is a simple ... person up to an almost-standing position within a ... by one assistant and does not require any ... that a child can operate it, and lightweight ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... June 23, 2017 , ... ... personal financial planning to families and business owners in North Central West Virginia, ... help provide services to differently abled residents in the region. , The Stepping ...
(Date:6/22/2017)... ... 2017 , ... Plastic Surgery Associates is proud to report that founding surgeon, ... research and information firm, Castle Connolly, releases their list of the most notable and ... 3rd time that Dr. Canales has been recognized by Castle Connolly. , ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... grant from the American Heart Association (AHA) to launch a Rheumatic Heart Disease ... the prevention and diagnosis of rheumatic heart disease (RHD) in high-risk, financially disadvantaged ...
(Date:6/22/2017)... ... June 22, 2017 , ... Vighter, a premier provider ... certification for ANSI/ASIS PSC.1-2012. The company’s work in countries throughout Southwest Asia, South ... law has been degraded. The PSC.1 standard was created to protect fundamental freedoms ...
(Date:6/20/2017)... ... June 20, 2017 , ... TwelveStone Health Partners, a premier ... private equity firm, has invested $3.35 million in the company. , “We ... Capital offers the smart money, speed to market and accountability we had been ...
Breaking Medicine News(10 mins):